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Background: Participation in epidemiological studies has fallen significantly over the past 30 years; this has been
attributed to a busier lifestyle and longer working hours. In case–control studies, participation among cases is
usually higher than among controls due to the personal relevance. In Australia, between 2003 and 2011, we
conducted three national population-based case–control studies of risk factors for childhood cancers; brain tumors,
acute leukemia and neuroblastoma and Wilms’ tumor. In this sub-study, we aimed to investigate factors that may
have influenced study participation and completeness of survey completion.
Findings: The proportion of incident cases that were eligible to participate was lowest in the brain tumor study
(Aus-CBT) (83.1%), as was the proportion of eligible families that consented (57%). The percentage of eligible cases that
consented was highest in the leukemia study (Aus-ALL) (80.2%). The mode of invitation used was associated with
families’ consent in each of the studies. Families invited in person, at clinic appointments, were more likely to consent
than families invited by letter or phone. Timing of invitation following the child’s diagnosis differed among studies but,
the likelihood of consent did not appear to be directly related to this. The return of questionnaires, completion of
interview, and provision of DNA (blood sample) was highest in Aus-ALL (93%) and lowest in Aus-CBT (81%).
Conclusions: Studies of childhood cancer, and possibly other childhood diseases, should arrange for the family to be
invited in person and, where possible, by a doctor with whom they are familiar. Whilst telephone interviews are time
consuming and costly, particularly for large studies, they should be preferred over questionnaires for obtaining
complete data.
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Background
Participation in epidemiological studies of all designs has
fallen significantly over the past 30 years [1,2]. These
falls in research participation have been attributed to
longer working hours, more families with both parents
working, and the demands of research on reduced family
time [1]. In addition, increased telemarketing and greater
numbers of study requests are believed to have created
an “over-surveyed” society, in which people are less will-
ing to volunteer their time [3-5].
In case–control studies, participation among cases is
usually higher than among controls. This is probably due* Correspondence: theiden@ichr.uwa.edu.au
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reproduction in any medium, provided the orto the much greater personal relevance of the topic to
cases [1]. Case participation is also falling, however; pro-
bably being affected by the factors affecting participation
in general as well as specific factors, such as the growing
frequency of opportunities and requests for people with
particular illnesses and conditions to participate in re-
search [1]. Studies involving children require the partici-
pation of parents and can have additional recruitment
challenges. Parents of children with a chronic illness may
view participation in epidemiological studies as risky be-
cause it is likely to evoke painful memories and feelings of
guilt [6].
The way in which a person is approached to participate
in a research study may influence their willingness to par-
ticipate. Among methods used to invite participants to a
study, “cold calls” or letters from unknown sources have
been shown to be the least successful [7]. Face-to-face
invitation has been highlighted as a preferred method ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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comes from someone known and trusted by the person
being asked to participate [7].
Because it is important to maximize participation in
order to draw valid inferences from research findings,
we set out to investigate factors that may influence par-
ticipation. To achieve this, we used information from
three national Australian case–control studies of differ-
ent childhood cancers conducted by our research group
between 2003 and 2010. Here we describe the results of
this novel sub-study.
Methods
The Australian Study of Causes of Acute Lymphoblastic
Leukaemia in Children (‘Aus-ALL’) [8] and The Australian
Study of Childhood Brain Tumours (‘Aus-CBT’) were
national population-based case–control studies, each con-
ducted over a five year period. Aus-ALL cases were
recruited between 2003 and 2007, and Aus-CBT cases
between 2006 and 2010. ISET was an international pilot
study of risk factors for Wilms’ tumour and neurobla-
stoma, initiated and coordinated by the International
Agency for Research on Cancer (IARC) in Lyon, France
and conducted in Australia in 2008.
Similar methods of recruitment were used in each
study. Case families were identified through the ten
paediatric oncology centres where virtually all children
with malignancies in Australia are treated. In each study,
collaborations were established with the designated lead
clinician at each hospital before the grant application
was submitted, and they estimated the numbers of diag-
noses expected during the course of the study. Key
issues and logistics relating to case recruitment were
discussed and agreed with the lead clinicians and their
clinical teams in face-to-face meetings or by telephone.
To be eligible to participate in any of the three studies,
case families were required to reside in Australia, and to
have at least one English-speaking biological parent,
preferably the mother, available to complete the ques-
tionnaires; the child must be alive at the time of consent.
In Aus-ALL, the child must also have achieved initial
remission; remission occurred in more than 99% of no-
tified cases.
The recruitment process used a series of electronic no-
tification forms. The treating hospital notified the coor-
dinating centre when i) a new case was diagnosed, ii)
when the family was invited to participate (or the reason
for not inviting them), and iii) when the family con-
sented or declined to participate. Three modes of invita-
tion were used to recruit families: a clinic visit (all three
studies), an invitation letter from the treating clinician
(Aus-CBT and ISET), or a telephone call from hospital
staff (Aus-CBT), depending on the frequency and timing
of clinic visits for the child’s cancer treatment and thepreference of the treating hospital. Since children with
ALL were seen by clinicians at weekly follow-up visits
for a prolonged period, all families were invited at a
clinic visit. Once parents consented to the study, the co-
ordinating centre mailed out the study information and
contacted families regarding data collection. In Aus-ALL
and Aus-CBT, information on demographic variables
and the exposures of interest were collected from par-
ents in mailed, self-administered questionnaires and
computer assisted telephone interviews. Blood samples
for DNA analysis were collected from case children and
their parents at the treating hospital. In ISET, similar in-
formation was collected by telephone interviews. DNA
samples were not collected in the ISET pilot study be-
cause Aus-ALL and Aus-CBT had already shown that
blood collection was feasible.
Ethics
Research and Ethics committees at all participating hos-
pitals approved the studies. Parental consent, and the
child’s consent when deemed appropriate, was obtained
for the collection of data and biological samples.
Statistical analysis
In this study, we compared participation levels in three
studies of different childhood cancers, and investigated
the effects that invitation modes and timing had on con-
sent and completeness of data collection. Where ap-
propriate, logistic regression analyses and chi squared
tests for differences in proportions were undertaken
using PASW statistics v18 (SPSS Inc., IBM Corporation,
Armonk, New York). Separate multivariable analyses
were run with consent and questionnaire completion as
dependent variables, and timing and mode of invitation
as independent variables for both. Timing of invitation
was treated as a categorical variable (<1 month, 1–
3 months, 4–6 months, 7–18 months, or >18 months
since diagnosis).
Results
The numbers and percentages of notifications, eligible
cases, invitations and consents for each of the studies
are shown in Table 1. The proportion of incident cases
who were eligible to participate was lowest for Aus-CBT,
as was the proportion of eligible families who consented.
The percentage of eligible cases who consented was
highest in Aus-ALL.
The main reason for ineligibility in Aus-ALL was not
having a parent who spoke English well enough to
complete the questionnaires, while in Aus-CBT it was that
the child died before their parents could be invited or give
their consent to participate in the study, reflecting the ag-
gressive nature of some types of CBT. There were very
few ineligible families in ISET. Some eligible families were
Table 1 Recruitment statistics in three Australian case–control studies of childhood cancer
Aus-ALL Aus-CBT ISET
Year(s) of diagnosis 2003-2006 2006-2010 2008
Type of cancer ALL Brain tumours Wilms’ tumour or neuroblastoma
Number of cases ascertained in the study period 568 792 82
Eligible (% of notifications) 519 (91.4%) 658 (83.1%) 78 (95.1%)
Invitations (% of eligible) 484 (93.3%) 560 (85.1%) 70 (89.7%)
Consent (% of eligible) 416 (80.2%) 374 (57.0%) 52 (66.6%)
ALL –Australian Study of Acute Lymphoblastic Leukemia,
CBT – Australian Study of Childhood Brain Tumours,
ISET – International study of Embryonal Tumours.
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appropriate for medical or psychosocial reasons. This oc-
curred less often in Aus-ALL (6.7% of eligible cases) than
in Aus-CBT and ISET (14.9% and 10.3% respectively)
(Table 1).
Factors influencing participation
In studies where more than one invitation mode was
used (Aus-CBT and ISET), the mode of invitation was
associated with consent. In both studies, families invited
at clinic appointments were more likely to consent than
families invited by letter or phone (Table 2). Further-
more, in Aus-CBT, a higher proportion of families in-
vited by phone consented to participate (62%) than
families invited by letter (48%); however, only 27 cases
were invited by phone, so statistical testing was not
done. Of the three studies, Aus-CBT had the lowest con-
sent fraction among families invited in clinic.
The time to invitation following the child’s diagnosis
differed among studies. The median number of days be-
tween diagnosis and invitation in a clinic appointment
was 84 days for Aus-ALL (~50 days from remission
when cases became eligible), 89 days for Aus-CBT and
70 days for ISET. Few Aus-ALL invitations were made
in the first month following diagnosis because of theTable 2 Number of families invited by each of the three
invitation modes and number of families consenting
based on invitation mode
Aus-ALL Aus-CBT ISET
Clinic invitations (% of all invitations) 484 (100%) 363 (65%) 62 (89%)
Letter invitations (% of all invitations) 170 (30%) 8 (11%)
Phone invitations (% of all invitations) 27 (5%)
Consent (% of all invited) 416 (86%) 374 (67%) 52 (74%)
Consent (% of invited in clinic) 416 (86%) 277 (76%) 49 (79%)
Consent (% of invited by letter) 81 (48%) 3 (38%)
Consent (% of invited by phone) 16 (62%)
ALL –Australian Study of Acute Lymphoblastic Leukemia,
CBT – Australian Study of Childhood Brain Tumours,
ISET – International Study of Embryonal Tumours.required delay until after remission, but a greater pro-
portion of Aus-ALL cases were invited within the first
five months following diagnosis than in Aus-CBT and
ISET (Table 3). The proportion of invitations in Aus-
CBT and ISET was highest in the first month following
diagnosis, but families continued to be invited over a
long time.
In Aus-ALL, over 85% of cases invited in clinic within
six months of diagnosis consented to the study. The cor-
responding proportions for Aus-CBT and ISET were
75% and 67% respectively. Generally, consent did not ap-
pear to be related to time of invitation within this six
month interval. However, there was a suggestion that
consent was less when Aus-CBT families were invited
close to the first anniversary of the child’s diagnosis
(65% in the three months around the anniversary) than
in the first 11 months after diagnosis (75%; p = 0.30).
Logistic regression analysis of the associations of mode
and time of invitation with consent in Aus-CBT cases
showed that clinic invitations resulted in a greater pro-
portion of consents than the other two modes of in-
vitation combined, independently of the time since
diagnosis. Families invited by telephone or letter were
approximately 60 percent less likely to consent than
those invited in clinic after adjusting for time since diag-
nosis (OR 0.39, 95% CI 0.25, 0.59). There was less evi-
dence that time since diagnosis affected the likelihood
of consent, after taking account of invitation mode
(Table 4).
Factors influencing completeness of participation
The completeness of participation – return of self-
administered questionnaires, completion of interview
and provision of DNA (blood sample) – also varied
among the three studies (Table 3). In Aus-ALL, high
proportions of families returned the questionnaires
(93%) and provided the child’s DNA (99%) and DNA
from both parents (87%). A high proportion of families
(88%) completed the telephone interview in ISET. The
proportion of families who provided survey data in Aus-
CBT (81%) was less than in both Aus-ALL and ISET,
Table 3 Collection of data for Aus-ALL, Aus-CBT and ISET from participants invited in the clinic
Aus-ALL1 Aus-CBT1 ISET2
Number consented 416 374 52
Time lag between consent and data collection (median days) 58 50 25
% of cases invited within 5 months of diagnosis 93.6% 72.1% 73.7%
Data collected (% of consented) 388 (93%) 301 (81%) 43 (88%)
DNA Sample from child (% of consented) 415 (99%) 358 (96%)
DNA sample from mother (% of consented) 414 (99%) 351 (94%)
DNA samples from child and both parents (% of consented) 363 (87%) 278 (74%)
1 Data were collected in a self-administered postal questionnaire.
2 Data were collected in a telephone interview.
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(74%) was less than in Aus-ALL.
While the proportion of families who consented to
Aus-CBT was highest in those invited in clinic (76%)
and lowest in those invited by letter (48%, p <0.001)
(Table 2), the proportion of consenting families who
returned the questionnaires was somewhat higher
among those who consented after being invited by letter
(87.7%); than in those invited in clinic (78.3%) (p = 0.07),
OR 1.39 (95% CI 0.97, 1.99) (Table 4).
Collection of data from parents was completed much
sooner when done by telephone interviews, as in ISET,
with the median time to study completion being only
half the time taken for the return of the questionnaires
in Aus-ALL and Aus-CBT (Table 3).
Discussion
We compared the proportions of families who participated
in three Australian case–control studies of childhood can-Table 4 Results obtained in logistic regression analysis




Clinic 1 (ref) -
Letter or phone 0.39 0.25, 0.59
Timing of invitation*
< 1 month since diagnosis 1 (ref) -
3-6 months since diagnosis 0.56 0.28, 1.41
4-6 months since diagnosis 0.51 0.23, 1.12
7-18 months since diagnosis 0.50 0.24, 1.06
>18 months since diagnosis 0.40 0.16, 0.99
Questionnaire Return
Mode of Invitation -
Clinic 1 (ref)
Letter 1.39 0.97, 1.99
OR = Odds Ratio, CI = Confidence Interval.
* Trend p-value with increasing time since diagnosis = 0.07.cers between 2003 and 2010. Our results suggest that the
nature and prognosis of the particular cancer, and its im-
pact on the family, may influence the likelihood of being
invited to take part by the doctor, and the decision to con-
sent among those who are invited.
The length of time between diagnosis and invitation to
participate varied by the type of cancer, and appeared to
be related to the mode of invitation; in turn, the mode
of invitation appeared to be the most important factor in
the proportion of consenting cases. In all three studies,
clinic invitations were most successful in recruiting case
families, even after taking account of time since diagno-
sis. However, when comparing only those invited in
clinic across the three studies, Aus-CBT had the lowest
proportion of consents and Aus-ALL the highest. The
differences in consent across the three studies were con-
sistent with differences in the treatment regimens and
prognosis, suggesting that participation in childhood
cancer studies may be lower when the child’s prognosis
is less favourable. Among ALL cases, 99% achieved re-
mission, and the overall five year survival rate is high
(80.6%) [9]. The five-year survival for Wilms’ tumour is
approximately 89%, while for neuroblastoma it is 68%
[9]. The treatment for CBT is often invasive and the out-
come less favorable, with a 50-78% five-year survival [9].
In addition, children who do survive often have sub-
stantial long term morbidity. Therefore, when the ex-
pected course of the child’s cancer is unpredictable,
parents may be less likely to participate in epidemio-
logical research.
Invitations by letter were less successful than clinic in-
vitations in obtaining consent. Previous epidemiological
studies have also found face-to-face invitations to be
most effective in recruitment [1]. Face-to-face invitations
were not always possible in Aus-CBT and ISET due to
the clinical course of the child’s disease, the treatment
approach, and the frequency of clinic visits. The stan-
dard treatment protocols used in Aus-ALL, where case
families had regular clinic visits for two years, provided
more opportunities for invitation during a clinic visit. In-
vitation by a clinician during a clinic visit provided the
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parents, thereby increasing the likelihood of consent [1].
Wherever possible, studies of childhood cancer, and pos-
sibly other childhood diseases, should arrange for the
family to be invited in person and, where possible, by a
doctor with whom they are familiar.
Completeness of data collection also differed across
the three studies, and was highest in Aus-ALL. This has
been observed in previous studies, with over 86% of par-
ticipants providing data in a previous study of ALL [10].
Observations by project staff and feedback from partici-
pating families suggested that differences in prognosis
and the degree to which families were coping influenced
survey completion. Parents in Aus-CBT reported that
they wanted to participate and therefore consented to
the study, but later become overwhelmed and unable to
complete the surveys. Completeness of participation in
ISET was advantaged through the use of telephone inter-
views for data collection, a method which has been shown
to result in better provision of data than self-administered
questionnaires [11,12]. Thus, while telephone interviews
are time consuming, costly and not always feasible for
large studies [13], they should be preferred over question-
naires for obtaining complete data.
Timing of the invitation itself did not appear to influ-
ence the likelihood of participation except, perhaps,
when it was near the anniversary of the child’s diagnosis.
Invitation timing is possibly one of the most sensitive
issues in childhood cancer research. Invitation in Aus-
ALL was dependent on the child first reaching remis-
sion, thereby having the advantage of the family being
invited in person and at a more appropriate stage, in
terms of disease prognosis. In Aus-CBT responses to
early invitations varied, with some families responding
positively, and others declining to participate. Inviting
families a long time after diagnosis, by any invitation
mode, provided mixed results: some families said they
were happy to help because their child was doing well,
while other families did not want to revisit the painful
memories associated with the diagnosis (unpublished
observations). We suggest that the timing of invitation
should be planned with a view to maximising the oppor-
tunity for in-person invitation, which, from our experi-
ence, will usually be soon after diagnosis.
In Aus-CBT, families consenting to research when in-
vited by letter were more likely to complete the study
questionnaires. Although an invitation by letter did not
appear to be the best method of obtaining consent, it
was valuable when the family needed more time to deal
with the diagnosis, were no longer having regular clinic
appointments or had moved to another treatment faci-
lity. It appeared that, if families had had this time and
still decided to take part, they were more likely to return
questionnaires than those who responded to an ap-proach sooner after the diagnosis. Anecdotally, these
families considered themselves lucky, most likely be-
cause treatment was out of the way and time had
allowed them to come to terms with the diagnosis. They
reported wanting to help prevent other families going
through a similar experience (unpublished observations).
Limitations
This study has some limitations. No information, other
than age and sex, was available for cases whose parents
declined to participate. It is possible that factors such as
socio-economic status may have influenced participa-
tion, but we were not able to collect this information.
Similarly, it was not possible to survey parents about
their reasons for declining to participate, and this could
have added useful information. Our studies were con-
ducted in different time periods across a span of seven
years, and it is possible that falls in volunteerism in
recent years, along with the increasing opportunities for
families to participate in other studies and clinical trials,
may have contributed to the lower participation in
Aus-CBT, the most recent of our studies.
Conclusions
Our results suggest that participation fractions in studies
of childhood cancer vary by diagnosis. Further, among
the variables studied, the mode of invitation was most
likely to influence study participation. Understanding the
contributions of these and other factors is likely to assist
in increasing participation of case families in research
studies, and thus increase the validity of the findings.
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